Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroendocrine Tumors 1Colorectal Neoplasms 1Carcinoid Tumor 1Adenoma, Islet Cell 1

Interventions

Fluorouracil 80Oxaliplatin 72Leucovorin 66Irinotecan 60Capecitabine 58Bevacizumab 57Cetuximab 43Folfox protocol 22Drug Therapy 22Neoadjuvant Therapy 19HMPL-013 17Colonoscopy 17regorafenib 15apatinib 11Panitumumab 11Chemotherapy, Adjuvant 11trifluridine tipiracil drug combination 10XELOX 10Laparoscopy 10IFL protocol 10sintilimab 9raltitrexed 9Radiotherapy 9Blood Specimen Collection 9Surveys and Questionnaires 8Surgical Procedures, Operative 8tislelizumab 7pembrolizumab 7Endoscopic Mucosal Resection 7Aspirin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Colorectal Neoplasms × recombinant interferon alpha 2b-like protein × Clear all
NCT02068131 2016-01-05

Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Cancer

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Phase 2 Unknown
30 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡